Receive our newsletter – data, insights and analysis delivered to you
  1. Comment
November 30, 2021updated 29 Dec 2021 4:41am

Use of virtual trials and CROs helps trial completion rate of rescue clinical trials

Recent data show the use of virtual components together with CROs increases the chances of success for rescue clinical trials.

By GlobalData Healthcare

Rescue clinical trials, which can have a delayed estimated start date or delayed estimated end date, often require outside sourcing, such as to contract research organisations (CROs), to successfully complete. GlobalData’s Pharma Intelligence Centre has compiled data on rescue trials, showing a trend in the completion rate.

Since the Covid-19 pandemic began, sponsors have turned to the use of virtual trials components to successfully initiate and complete trials. When looking at the completion rate of rescue trials since 2010, those with virtual components had a higher completion rate by 3.2%. Rescue trials that used both virtual components and a CRO did even better, with an 84.5% completion rate compared with trials that had neither virtual components nor CROs (78.8%), as seen in Figure 1. These data points indicate that the usage of not only virtual components, but also CROs, increases the chances of successfully completing a rescue clinical trial.

Related Companies

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide
Why Asia-Pacific is the next frontier for decentralized clinical trials
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU